Abstract
We applied spectral dynamic causal modelling (spDCM; Friston et al., 2014) to analyze the effective connectivity differences between the nodes of three resting state networks (i.e. Default mode network/DMN, Salience network/SAN and Dorsal attention network/DAN) in a dataset of 31 healthy controls (HC) and 25 patients with schizophrenia (SZ), all male. Patients showed increased connectivity from the left hippocampus (LHC) to the dorsal anterior cingulate cortex (DACC), right anterior insula (RAI), left frontal eye fields (LFEF) and the bilateral inferior parietal sulcus (LIPS & RIPS), as well as increased connectivity from the right hippocampus (RHC) to the bilateral anterior insula (LAI & RAI), right frontal eye fields (RFEF) and RIPS. Moreover, negative symptoms predicted the connectivity strengths from the LHC to the DACC, the left inferior parietal sulcus (LIPAR) and the RHC, while positive symptoms predicted the connectivity strengths from the LHC to the LIPAR and from the RHC to the LHC. These results reinforce the crucial role of hippocampus dysconnectivity in SZ pathology and its potential as a biomarker of disease severity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants provided to Martin Kronbichler by the Austrian Science Fund (grant number: P 30390-B27) and the Scientific Funds of the Paracelsus Medical University (grant number: E-13/18/097-KRO).
Additionally, this work was also financially supported by the Doctoral College “Imaging the Mind” of the Austrian Science Fund (FWF; W1233-G17; PhD student Lavinia Carmen Uscătescu; supervising faculty member Martin Kronbicher).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available upon request.